SEC 13F Intelligence

D. E. Shaw & Co., Inc. / BSX

D. E. Shaw & Co., Inc.’s Boston Scientific Corp Position

Does D. E. Shaw & Co., Inc. own Boston Scientific Corp (BSX)? Yes — 24.31M shares worth $1.5B (+0.92% of its 13F portfolio) as of Q1 2026, up from 11.25M shares the prior filed quarter.

Position Value
$1.5B
Q1 2026
Shares
24.31M
% of Portfolio
+0.92%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $25MQ2 ’19: $18MQ3 ’19: $5MQ4 ’19: $11MQ4 ’19Q1 ’20: $109MQ2 ’20: $111MQ3 ’20: $23MQ4 ’20: $358MQ4 ’20Q1 ’21: $67MQ2 ’21: $4MQ3 ’21: $14MQ4 ’21: $62MQ4 ’21Q1 ’22: $26MQ2 ’22: $100MQ3 ’22: $71MQ4 ’22: $38MQ4 ’22Q1 ’23: $24MQ2 ’23: $63MQ3 ’23: $60MQ4 ’23: $30MQ4 ’23Q1 ’24: $96MQ2 ’24: $63MQ3 ’24: $147MQ4 ’24: $68MQ4 ’24Q1 ’25: $387MQ2 ’25: $726MQ3 ’25: $870MQ4 ’25: $1.1BQ4 ’25Q1 ’26: $1.5Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202624.31M$1.5B+0.92%
Q4 202511.25M$1.1B+0.59%
Q3 20258.91M$870M+0.49%
Q2 20256.76M$726M+0.51%
Q1 20253.84M$387M+0.34%
Q4 2024763.5K$68M+0.05%
Q3 20241.76M$147M+0.13%
Q2 2024818.6K$63M+0.06%
Q1 20241.40M$96M+0.08%
Q4 2023519.5K$30M+0.03%
Q3 20231.14M$60M+0.06%
Q2 20231.17M$63M+0.06%
Q1 2023471.8K$24M+0.03%
Q4 2022827.1K$38M+0.04%
Q3 20221.82M$71M+0.08%
Q2 20222.68M$100M+0.12%
Q1 2022584.2K$26M+0.02%
Q4 20211.46M$62M+0.05%
Q3 2021318.0K$14M+0.01%
Q2 2021100.8K$4M0.00%
Q1 20211.74M$67M+0.06%
Q4 20209.95M$358M+0.32%
Q3 2020605.6K$23M+0.02%
Q2 20203.15M$111M+0.13%
Q1 20203.35M$109M+0.17%
Q4 2019244.6K$11M+0.01%
Q3 2019116.9K$5M+0.01%
Q2 2019422.5K$18M+0.02%
Q1 2019649.7K$25M+0.03%
Q4 2018125.6K$4M+0.01%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of BSX.